Molecular distinction between pathogenic and infectious properties of the prion protein

Journal of Virology

Volumn 77, Issue 13, 2003, Pages 7611-7622

  Chiesa, Roberto ^a,b   Piccardo, Pedro ^c,d   Quaglio, Elena ^a,e   Drisaldi, Bettina ^a,f   Si Hoe, San Ling ^a   Takao, Masaki ^c,g   Ghetti, Bernardino ^c   Harris, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DULBECCO TELETHON INSTITUTE   (Italy)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f UNIVERSITY OF TORONTO   (Canada)

^g KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; CONTROLLED STUDY; GENE INSERTION; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; TRANSGENIC MOUSE;

ANIMALS; MICE; MICE, TRANSGENIC; PRIONS; PROTEIN CONFORMATION; SCRAPIE;

EID: 0038128629     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.13.7611-7622.2003     Document Type: Article

References (51)

1. Bessen, R. A., and R. F. Marsh. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68:7859-7868.
2. Brown, P., C. J. Gibbs, P. Rodgers-Johnson, D. M. Asher, M. P. Sulima, A. Bacote, L. G. Goldfarb, and D. C. Gajdusek. 1994. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35:513-529.
3. Bucciantini, M., E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson, and M. Stefani. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507-511.
4. Büeler, H., M. Fischer, Y. Lang, H. Fluethmann, H.-P. Lipp, S. J. DeArmond, S. B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
5. Caughey, B., G. J. Raymond, M. A. Callahan, C. Wong, G. S. Baron, and L. W. Xiong. 2001. Interactions and conversions of prion protein isoforms. Adv. Protein Chem. 57:139-169.
6. Chandler, R. L. 1971. Experimental transmission of scrapie to voles and Chinese hamsters. Lancet i:232-233.
7. Chiesa, R., B. Drisaldi, E. Quaglio, A. Migheli, P. Piccardo, B. Ghetti, and D. A. Harris. 2000. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc. Natl. Acad. Sci. USA 97:5574-5579.
8. Chiesa, R., and D. A. Harris. 2001. Prion diseases: what is the neurotoxic molecule? Neurobiol. Dis. 8:743-763.
9. Sc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol. Dis. 8:279-288.
10. Chiesa, R., P. Piccardo, B. Ghetti, and D. A. Harris. 1998. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339-1351.
11. Collinge, J. 2001. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24:519-550.
12. Drisaldi, B., R. S. Stewart, C. Adles, L. R. Stewart, E. Quaglio, E. Biasini, L. Fioriti, R. Chiesa, and D. A. Harris. 2003. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither mutant nor wild-type PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 10.1074/jbc.M213247200.
13. Duchen, L. W., M. Poulter, and A. E. Harding. 1993. Dementia associated with a 216 base pair insertion in the prion protein gene: clinical and neuropathological features. Brain 116:555-567.
14. Flechsig, E., D. Shmerling, I. Hegyi, A. J. Raeber, M. Fischer, A. Cozzio, C. von Mering, A. Aguzzi, and C. Weissmann. 2000. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27:399-408.
15. Goldfarb, L. G., P. Brown, W. R. McCombie, D. Goldgaber, G. D. Swergold, P. R. Wills, L. Cervenakova, H. Baron, C. J. Gibbs, Jr., and D. C. Gajdusek. 1991. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc. Natl. Acad. Sci. USA 88:10926-10930.
16. Hegde, R. S., J. A. Mastrianni, M. R. Scott, K. A. Defea, P. Tremblay, M. Torchia, S. J. DeArmond, S. B. Prusiner, and V. R. Lingappa. 1998. A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827-834.
17. Hegde, R. S., P. Tremblay, D. Groth, S. J. DeArmond, S. B. Prusiner, and V. R. Lingappa. 1999. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822-826.
18. Hill, A. F., S. Joiner, J. Linehan, M. Desbruslais, P. L. Lantos, and J. Collinge. 2000. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl. Acad. Sci. USA 97:10248-10253.
19. Hsiao, K. K., D. Groth, M. Scott, S.-L. Yang, H. Serban, D. Rapp, D. Foster, M. Torchia, S. J. DeArmond, and S. B. Prusiner. 1994. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91:9126-9130.
20. Hsiao, K. K., M. Scott, D. Foster, D. F. Groth, S. J. DeArmond, and S. B. Prusiner. 1990. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587-1590.
21. Kaneko, K., H. L. Ball, H. Wille, H. Zhang, D. Groth, M. Torchia, P. Tremblay, J. Safar, S. B. Prusiner, S. J. DeArmond, M. A. Baldwin, and F. E. Cohen. 2000. A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. J. Mol. Biol. 295:997-1007.
22. Krasemann, S., I. Zerr, T. Weber, S. Poser, H. Kretzschmar, G. Hunsmann, and W. Bodemer. 1995. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Mol. Brain Res. 34:173-176.
23. Lasmezas, C. I., J. P. Deslys, O. Robain, A. Jaegly, V. Beringue, J. M. Peyrin, J. G. Fournier, J. J. Hauw, J. Rossier, and D. Dormont. 1997. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402-405.
24. Lehmann, S., and D. A. Harris. 1995. A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270:24589-24597.
25. Sc-like conformation in the cytosol. Science 298:1785-1788.
26. Ma, J., R. Wollmann, and S. Lindquist. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298:1781-1785.
27. Mallucci, G. R., S. Ratte, E. A. Asante, J. Linehan, I. Gowland, J. G. Jefferys, and J. Collinge. 2002. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21:202-210.
28. Manson, J. C., A. R. Clarke, M. L. Hooper, L. Aitchison, I. McConnell, and J. Hope. 1994. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8:121-127.
29. Manson, J. C., E. Jamieson, H. Baybutt, N. L. Tuzi, R. Barron, I. McConnell, R. Somerville, J. Ironside, R. Will, M. S. Sy, D. W. Melton, J. Hope, and C. Bostock. 1999. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 18:6855-6864.
30. Muramoto, T., S. J. DeArmond, M. Scott, G. C. Telling, F. E. Cohen, and S. B. Prusiner. 1997. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix. Nat. Med. 3:750-755.
31. Owen, F., M. Poulter, J. Collinge, M. Leach, R. Lofthouse, T. J. Crow, and A. E. Harding. 1992. A dementing illness associated with a novel insertion in the prion protein gene. Mol. Brain Res. 13:155-157.
32. Parchi, P., A. Giese, S. Capellari, P. Brown, W. Schulz-Schaeffer, O. Windl, I. Zerr, H. Budka, N. Kopp, P. Piccardo, S. Poser, A. Rojiani, N. Streichemberger, J. Julien, C. Vital, B. Ghetti, P. Gambetti, and H. Kretzschmar. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46:224-233.
33. Peretz, D., R. A. Williamson, Y. Matsunaga, H. Serban, C. Pinilla, R. B. Bastidas, R. Rozenshteyn, T. L. James, R. A. Houghten, F. E. Cohen, S. B. Prusiner, and D. R. Burton. 1997. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273:614-622.
34. Piccardo, P., J. J. Liepnieks, A. William, S. R. Dlouhy, M. R. Farlow, K. Young, D. Nochlin, T. D. Bird, R. R. Nixon, M. J. Ball, C. DeCarli, O. Bugiani, F. Tagliavini, M. D. Benson, and B. Ghetti. 2001. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am. J. Pathol. 158:2201-2207.
35. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
36. Race, R., A. Raines, G. J. Raymond, B. Caughey, and B. Chesebro. 2001. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J. Virol. 75:10106-10112.
37. Sc molecules with different conformations. Nat. Med. 4:1157-1165.
38. Shmerling, D., I. Hegyi, M. Fischer, T. Blättler, S. Brandner, J. Götz, T. Rülicke, E. Flechsig, A. Cozzlo, C. von Mering, C. Hangartner, A. Aguzzi, and C. Weissmann. 1998. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203-214.
39. Supattapone, S., E. Bouzamondo, H. L. Ball, H. Wille, H. O. Nguyen, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and M. Scott. 2001. A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice. Mol. Cell. Biol. 21:2608-2616.
40. Supattapone, S., T. Muramoto, G. Legname, I. Mehlhorn, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and M. R. Scott. 2001. Identification of two prion protein regions that modify scrapie incubation time. J. Virol. 75:1408-1413.
41. Supattapone, S., H. O. Nguyen, T. Muramoto, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and M. Scott. 2000. Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations. J. Virol. 74:11928-11934.
42. Taraboulos, A., K. Jendroska, D. Serban, S.-L. Yang, S. J. DeArmond, and S. B. Prusiner. 1992. Regional mapping of prion proteins in brain. Proc. Natl. Acad. Sci. USA 89:7620-7624.
43. Tateishi, J., and T. Kitamoto. 1995. Inherited prion diseases and transmission to rodents. Brain Pathol. 5:53-59.
44. Tateishi, J., T. Kitamoto, K. Doh-Ura, Y. Sakaki, G. Steinmetz, C. Tranchant, J. M. Warter, and N. Heldt. 1990. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology 40:1578-1581.
45. Tateishi, J., T. Kitamoto, M. Z. Hoque, and H. Furukawa. 1996. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 46:532-537.
46. Taylor, J. P., J. Hardy, and K. H. Fischbeck. 2002. Toxic proteins in neurodegenerative disease. Science 296:1991-1995.
47. Telling, G. C., T. Haga, M. Torchia, P. Tremblay, S. J. DeArmond, and S. B. Prusiner. 1996. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 10:1736-1750.
48. Telling, G. C., P. Parchi, S. J. DeArmond, P. Cortelli, P. Montagna, R. Gabizon, J. Mastriani, E. Lugaresi, P. Gambetti, and S. B. Prusiner. 1996. Evidence for the formation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
49. Uptain, S. M., and S. Lindquist. 2002. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56:703-741.
50. Walsh, D. M., I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S. Wolfe, M. J. Rowan, and D. J. Selkoe. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539.
51. Westaway, D., S. J. DeArmond, J. Cayetano-Canlas, D. Groth, D. Foster, S.-L. Yang, M. Torchia, G. A. Carlson, and S. B. Prusiner. 1994. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76:117-129.